Adopting the New Therapeutic “Lineup” to Manage ASCVD - Central

Join expert faculty to ensure you’re appropriately managing the care of your patients with ASCVD.

Live Meeting
3.50 available credits
Information
April 04, 2022
05:15 PM - 09:30 PM CDT
TBA
Houston, Texas, United States
ReachMD Healthcare Image
Choose a format
Details
Comments
  • Overview

    Managing patients with established CVD presents challenges in our practice every day. These patients may have had a prior stroke or MI and are at a very high risk of future life-threatening CV events. Join our expert faculty to hear the latest data on new and emerging statin adjuncts presented in a highly relevant and clinically applicable format. Barriers to the optimal management of ASCVD risk in many patient types (ethnicity/race/sex) will be addressed, and solutions to effectively manage such challenges in your everyday clinical practice will be provided. 

  • Program Schedule

    Coming Soon!

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Understand the key findings of large-scale omega-3 fatty acid clinical trials and how this information relates to reducing ASCVD events in clinical practice
    • Apply recent clinical trial evidence of EPA on a case-by-case basis for patients with established CVD who are on statins and at risk of further CV events
    • Identify barriers to the implementation of effective, long-term management of ASCVD
  • Target Audience

    This activity is designed to meet the educational needs of primary care physicians and community pharmacists.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • Commercial Support

    This activity is supported by an independent educational grant from Amarin Pharma, Inc.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.

Facebook Comments

Details
Comments
  • Overview

    Managing patients with established CVD presents challenges in our practice every day. These patients may have had a prior stroke or MI and are at a very high risk of future life-threatening CV events. Join our expert faculty to hear the latest data on new and emerging statin adjuncts presented in a highly relevant and clinically applicable format. Barriers to the optimal management of ASCVD risk in many patient types (ethnicity/race/sex) will be addressed, and solutions to effectively manage such challenges in your everyday clinical practice will be provided. 

  • Program Schedule

    Coming Soon!

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Understand the key findings of large-scale omega-3 fatty acid clinical trials and how this information relates to reducing ASCVD events in clinical practice
    • Apply recent clinical trial evidence of EPA on a case-by-case basis for patients with established CVD who are on statins and at risk of further CV events
    • Identify barriers to the implementation of effective, long-term management of ASCVD
  • Target Audience

    This activity is designed to meet the educational needs of primary care physicians and community pharmacists.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • Commercial Support

    This activity is supported by an independent educational grant from Amarin Pharma, Inc.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free